Synapse - Howard Scher

Results (20)

Morphology-predicted large-scale transition number in circulating tumor cells identifies a chromosomal instability biomarker associated with poor outcome in castration-resistant prostate cancer

Journal Article

Schonhoft, J. D.; Zhao, J. L.; Jendrisak, A.; Carbone, E. A.; Barnett, E. S.; Hullings, M. A.; Gill, A.; Sutton, R.; Lee, J.; Dago, A. E.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer

Journal Article

Stopsack, K. H.; Nandakumar, S.; Wibmer, A. G.; Haywood, S.; Weg, E. S.; Barnett, E. S.; Kim, C. J.; Carbone, E. A.; Vasselman, S. E.; Nguyen, B.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Minimum technical data elements for liquid biopsy data submitted to public databases

Guidelines

Febbo, P. G.; Martin, A. M.; Scher, H. I.; Barrett, J. C.; Beaver, J. A.; Beresford, P. J.; Blumenthal, G. M.; Bramlett, K.; Compton, C.; Dittamore, R.; more...
Clinical Pharmacology & Therapeutics (2020)

Fulltext@MSK | Save

Clinical utility of the nuclear-localized AR-V7 biomarker in circulating tumor cells in improving physician treatment choice in castration-resistant prostate cancer

Journal Article

Graf, R. P.; Hullings, M.; Barnett, E. S.; Carbone, E.; Dittamore, R.; Scher, H. I.
European Urology (2020)

Fulltext@MSK | Save

CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts)

Meeting Abstract

Scher, H. I.; Lee, J.; Dago, A. E.; Barnett, E.; Sutton, R.; Carbone, E.; Schreiber, N. A.; Hullings, M.; Ebrahim, N.; Landers, M. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Morphology-predicted, large-scale transition (LST) number in circulating tumor cells (CTC) as a biomarker of chromosomal instability (CIN) to assess early resistance to standard of care (SOC) drugs in mCRPC

Meeting Abstract

Scher, H. I.; Schonhoft, J.; Hullings, M.; Carbone, E.; Barnett, E.; Sutton, R.; Jendrisak, A.; Landers, M. A.; Wang, Y.; Dittamore, R.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy

Meeting Abstract

Fernandez, L.; Poirier, J.; Rodriguez, A.; Hulling, M.; Richardson, R.; Sutton, R.; Jiles, R.; Schonhoft, J.; Lee, J.; Ebrahim, N.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade

Journal Article

Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
JAMA Oncology (2019)

Fulltext@MSK | Save

Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples

Meeting Abstract

Scher, H. I.; Dago, A. E.; Lee, J.; Sutton, R.; Graf, R. P.; Schreiber, N. A.; Hullings, M.; Wang, Y.; Landers, M. A.; Solit, D. B.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Unique patterns of the selection and change in circulating tumor cell (CTC) phenotypes and genotypes by drug class in metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Scher, H. I.; Schonhoft, J.; Graf, R. P.; Dago, A. E.; Lee, J.; Sutton, R.; Schreiber, N. A.; Hullings, M.; Jendrisak, A.; Wang, Y.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save